What is the most recent earnings date for HUMA stock?
HUMACYTE INC (HUMA) last reported earnings on 3/27/2026.
HUMACYTE INC (HUMA) Earnings History & Surprises
NASDAQ:HUMA • US44486Q1031
Current stock price
0.6069 USD
-0.04 (-6.63%)
At close:
0.6401 USD
+0.03 (+5.47%)
Pre-Market:
HUMA Earnings overview
Past quarterly earnings results for HUMACYTE INC (HUMA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 11, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.11
- Revenue Estimate
- 2.181M
Last Reported
Most Recent- Release Date
- Mar 27, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.13
- EPS Surprise
- 3.20%
- Revenue Surprise
- -65.91%
Beat Rate
Last 8 Quarters 25%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.13 | -0.13 | 3.20% | 18.75% | 467K | 1.37M | -65.91% | - |
| Q3 2025 | -0.11 | -0.16 | 31.89% | 66.67% | 753K | 940.777K | -19.96% | - |
| Q2 2025 | -0.24 | -0.16 | -45.54% | 50.00% | 301K | 1.023M | -70.58% | - |
| Q1 2025 | 0.28 | -0.19 | 244.48% | 196.55% | 517K | 775.537K | -33.34% | - |
| Q4 2024 | -0.16 | -0.26 | 37.25% | 33.33% | 218.576K | -100.00% | - | |
| Q3 2024 | -0.33 | -0.25 | -30.16% | -32.00% | - | - | ||
| Q2 2024 | -0.48 | -0.24 | -97.73% | -118.18% | - | - | ||
| Q1 2024 | -0.29 | -0.23 | -26.36% | 19.44% | - | - | ||
| Q4 2023 | -0.24 | -0.25 | 3.91% | -500.00% | 58.283K | -100.00% | - | |
| Q3 2023 | -0.25 | -0.26 | 3.25% | - | 68.003K | -100.00% | -100.00% | |
| Q2 2023 | -0.22 | -0.22 | 1.81% | -162.86% | 68.003K | -100.00% | -100.00% | |
| Q1 2023 | -0.36 | -0.21 | -68.39% | -89.47% | 168.912K | -100.00% | -100.00% | |
| Q4 2022 | -0.04 | -0.24 | 83.31% | -109.76% | 200.093K | -100.00% | -100.00% | |
| Q3 2022 | -0.25 | -0.22 | -14.00% | 65.28% | 30K | 207.57K | -85.55% | -87.50% |
| Q2 2022 | 0.35 | -0.22 | 257.16% | - | 1.3M | 208.59K | 523.23% | 88.41% |
| Q1 2022 | -0.19 | -0.21 | 9.87% | 5.00% | 230K | 250.308K | -8.11% | 43.75% |
| Q4 2021 | 0.41 | -0.21 | 296.08% | - | 180K | 259.08K | -30.52% | 50.00% |
| Q3 2021 | -0.72 | -0.21 | -243.78% | - | 240K | 379.103K | -36.69% | -73.63% |
| Q2 2021 | 0.00 | -0.58 | 100.00% | - | 690K | 102K | 576.47% | - |
| Q1 2021 | -0.20 | -0.92 | 78.21% | - | 160K | - | - | |
| Q4 2020 | - | - | 120K | - | - | |||
| Q3 2020 | - | - | 910K | - | - | |||
| Q2 2020 | - | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
58.51%
Max EPS beat (4)
244.48%
Min EPS beat (4)
-45.54%
Revenue beat statistics
Revenue beat (4)
0
Average Revenue beat (4)
-47.45%
Max Revenue beat (4)
-19.96%
Min Revenue beat (4)
-70.58%
Analysis
In the last 4 quarters, HUMA has beaten EPS estimates in 3 out of 4 releases
HUMA has not beaten revenue estimates in any of the last 4 earnings releases
In the last 4 quarters, HUMA has beaten the EPS estimates by 58.5% on average.
In the last 4 quarters, HUMA reported -47.4% below the revenue estimates on average.
Related analysis
HUMACYTE INC / HUMA Earnings FAQ
Did HUMA stock beat earnings estimates in the most recent quarter?
HUMACYTE INC (HUMA) beat EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does HUMA stock beat earnings estimates?
In the last 4 quarters, HUMACYTE INC (HUMA) has beaten EPS estimates in 3 out of 4 releases.